This site is intended only for the use of Canadian Healthcare Professionals

Choose language:

Open Search
Open Menu

Gastrointestinal Tolerance of an Amino Acid-Based Formula in Children After a Formula Switch: A Retrospective Study (ASPEN Poster 2024)

In this retrospective analysis of USA claims data, patient and clinical characteristics were analyzed in children 1-13 years who initially received a recalled amino acid-based formula (AAF) as their baseline formula, and switched to Alfamino Junior in post-acute care settings (homecare). Switching to Alfamino Junior was effective, with improved gastrointestinal tolerance in 45% of community-based children. This poster was presented at the ASPEN Nutrition Science & Practice Conference in March 2024.

This site is intended only for Canadian healthcare professionals. The products discussed in this site may have different product labeling in different countries.
In the event of a discrepancy between website information and product packaging, please refer to product packaging.
The information provided is for educational purposes only.

All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland and used under license. ©2025 Nestlé.